- Q3 2022 Vivesto AB Earnings Call TranscriptNov 17, 2022$0.35Earnings
- Q2 2022 Vivesto AB Earnings Call TranscriptAug 25, 2022$0.1Earnings
- Q1 2022 Vivesto AB Earnings Call TranscriptMay 25, 2022$0.2253Earnings
- Q4 2021 Oasmia Pharmaceutical AB Earnings Call TranscriptFeb 24, 2022$0.525Earnings
- Oasmia Pharmaceutical AB Online Presentation TranscriptJan 19, 2022
- Q3 2021 Oasmia Pharmaceutical AB Earnings Call TranscriptNov 18, 2021$0.7135Earnings
- Q2 2021 Oasmia Pharmaceutical AB Earnings Call TranscriptAug 19, 2021$0.92255Earnings
- Oasmia Pharmaceutical AB (publ) - Special Call TranscriptMar 01, 2021
- Full Year 2020 Oasmia Pharmaceutical AB Earnings Call TranscriptFeb 19, 2021$1.1Earnings
- Q2 2021 Oasmia Pharmaceutical AB Earnings Call TranscriptDec 09, 2020$1.33Earnings
- LSK BioPartners, Inc., Oasmia Pharmaceutical AB (publ) - Special Call TranscriptDec 03, 2020
- Vivesto AB at Sachs Associates Biotech in Europe Forum (Virtual) TranscriptSep 21, 2020
- Q1 2021 Oasmia Pharmaceutical AB Earnings Call TranscriptSep 09, 2020$1.67Earnings
- Q4 2020 Oasmia Pharmaceutical AB Earnings Call TranscriptJun 18, 2020$1.9Earnings
Q2 2022 Vivesto AB Earnings Call Transcript
Okay. Well, thank you so much. Sorry about this delay here. We've had some technical challenges, but hopefully, everything will work here soon. Anyway, this morning, we announced our Q2 2022 results, which we will be taking you through in this presentation. As usual, we'll run through the highlights and the financials and then take any questions at the end of the presentation.
Next slide, please. Yes. Here are some important legal and forward-looking statements that you should be aware of.
And next slide, please. Today, I'll be presenting to you together with our acting CFO, Maiorana, but I would like to start by introducing myself, and Robert will also give a brief presentation of himself.
And as you may know, I joined as acting CEO in late July, and I have some fairly long background in the pharma industry. I spent more than 20 years in various executive positions in R&D at companies like Hoffman-LaRoche, Eli Lilly, AstraZeneca, Orion in Finland and 20 years in various positions in the pharma industry, and I joined here in late
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)